Teen motHers' ReproductIve and behaVioral Health intErvention in Barbados
NCT07149948 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2026-01-06
Summary
The goal of this clinical trial is to learn if an integrated care program can help improve overall health and prevent repeat pregnancy in teen mothers in Barbados. The study focuses on young women ages 10 to 25 who became pregnant during their teenage years and are experiencing stress or mood-related symptoms. This study is currently pending ethics committee review and has not yet begun enrolling participants.
The main questions it aims to answer are:
* Does the THRIVE program improve participants' mental health and parenting skills?
* Does the program help prevent repeat, unplanned pregnancies?
Researchers will compare participants who receive the THRIVE program to those who receive standard care to see if the program leads to better physical and emotional health.
Participants will:
* Take part in seven biweekly in-person or virtual sessions focused on reproductive and behavioral health;
* Complete health checks and questionnaires about their mood, parenting stress, and support;
* Receive follow-up contact after the sessions are completed.
The THRIVE program includes education on sexual health, mental health, parenting, and life skills. Participants will receive small incentives and support throughout the study. All study activities will begin only after full ethics approval is obtained.
Conditions
- Pregnancy in Adolescence
Interventions
- BEHAVIORAL
-
THRIVE Integrated Care Program
The THRIVE Integrated Care Program is a psychoeducational behavioral intervention for adolescent mothers that combines reproductive health education and mental health support. It includes seven biweekly in-person or virtual sessions covering topics such as sexual health, parenting, mental health, substance use prevention, social support, and professional development. The intervention is delivered by trained medical students and staff using interactive learning modules and assessments.
Sponsors & Collaborators
-
Rotary Club of Barbados
collaborator UNKNOWN -
Hada Fongha Ieong, PhD
lead OTHER
Principal Investigators
-
Hada Fongha Ieong, PhD
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 10 Years
- Max Age
- 25 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-01
- Primary Completion
- 2028-12-30
- Completion
- 2028-12-30
Countries
- Barbados
Study Locations
More Related Trials
-
Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children
NCT00032669 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Blood Levels of Tenofovir Disoproxil Fumarate in HIV Infected Pregnant Women and Their Babies
NCT00120471 ·Status: COMPLETED ·Phase: PHASE1
-
Adolescent Master Protocol
NCT01418014 ·Status: COMPLETED
-
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns
NCT00000642 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial on the Effects of Progestin-based Contraception in the Genital Tract of HIV-infected and Uninfected Women
NCT02103660 ·Status: COMPLETED ·Phase: PHASE4
-
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
NCT02140255 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum
NCT04518228 ·Status: COMPLETED
-
Optimizing Prevention and Care for Pregnant and Postpartum Adolescent Girls and Young Women With HIV in Tanzania
NCT06605053 ·Status: RECRUITING ·Phase: NA
-
Evaluating the Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for HIV Prevention During Pregnancy and Postpartum
NCT03386578 ·Status: COMPLETED ·Phase: PHASE2
-
IMPAACT P1074: Long-Term Outcomes in HIV-Infected Infants, Children, and Adolescents
NCT01061164 ·Status: COMPLETED
-
Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor
NCT00001826 ·Status: COMPLETED
-
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
NCT00404989 ·Status: RECRUITING
-
EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)
NCT01209754 ·Status: COMPLETED
-
Contraceptive/HIV Affecting Risk in Adolescents
NCT03301480 ·Status: TERMINATED
-
Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1
NCT06517693 ·Status: RECRUITING ·Phase: PHASE1
-
Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants
NCT00076791 ·Status: COMPLETED ·Phase: PHASE1
-
Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery
NCT00540605 ·Status: COMPLETED ·Phase: PHASE1
-
Heart Function in HIV-Negative Children Exposed to HIV and HAART
NCT01107834 ·Status: COMPLETED
-
Evaluation of Raltegravir During the Third Trimester of Pregnancy
NCT02099474 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Effects of Highly Active Anti-Retroviral Therapy on HIV-Infected Children
NCT00260806 ·Status: COMPLETED
-
A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral Therapy
NCT01789879 ·Status: COMPLETED ·Phase: PHASE2
-
Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission
NCT00021671 ·Status: COMPLETED ·Phase: PHASE3
-
UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study
NCT06158126 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Maternal Anti-HIV Treatment on Infants Born to HIV-Infected Women
NCT00100867 ·Status: COMPLETED
-
IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum Women
NCT00955968 ·Status: COMPLETED ·Phase: PHASE4